paolo magni
Cited by
Cited by
Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54
VM Navarro, JM Castellano, R Fernández-Fernández, S Tovar, J Roa, ...
Endocrinology 146 (1), 156-163, 2005
Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery
GD Norata, S Raselli, L Grigore, K Garlaschelli, E Dozio, P Magni, ...
Stroke 38 (10), 2844-2846, 2007
Ontogeny and mechanisms of action for the stimulatory effect of kisspeptin on gonadotropin-releasing hormone system of the rat
JM Castellano, VM Navarro, R Fernandez-Fernandez, JP Castano, ...
Molecular and cellular endocrinology 257, 75-83, 2006
Expression of a leptin receptor in immortalized gonadotropin-releasing hormone-secreting neurons
P Magni, R Vettor, C Pagano, A Calcagno, E Beretta, E Messi, M Zanisi, ...
Endocrinology 140 (4), 1581-1585, 1999
Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest
G Biolo, F Agostini, B Simunic, M Sturma, L Torelli, JC Preiser, ...
The American journal of clinical nutrition 88 (4), 950-958, 2008
Leptin: a possible link between food intake, energy expenditure, and reproductive function
P Magni, M Motta, L Martini
Regulatory peptides 92 (1-3), 51-56, 2000
Dietary iron overload induces visceral adipose tissue insulin resistance
P Dongiovanni, M Ruscica, R Rametta, S Recalcati, L Steffani, S Gatti, ...
The American journal of pathology 182 (6), 2254-2263, 2013
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
IJ Neeland, R Ross, JP Després, Y Matsuzawa, S Yamashita, I Shai, ...
The lancet Diabetes & endocrinology 7 (9), 715-725, 2019
Molecular aspects of adipokine-bone interactions
P Magni, E Dozio, E Galliera, M Ruscica, MM Corsi
Current molecular medicine 10 (6), 522-532, 2010
Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1
S Della Torre, G Rando, C Meda, A Stell, P Chambon, A Krust, C Ibarra, ...
Cell metabolism 13 (2), 205-214, 2011
Pharmacokinetics of orally administered melatonin in critically ill patients
G Mistraletti, G Sabbatini, M Taverna, MA Figini, M Umbrello, P Magni, ...
Journal of pineal research 48 (2), 142-147, 2010
Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin‐sensitivity, lipid profile and …
P Magni, A Liuzzi, M Ruscica, E Dozio, S Ferrario, I Bussi, A Minocci, ...
Clinical endocrinology 62 (2), 189-196, 2005
The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells
E Dozio, M Ruscica, L Passafaro, G Dogliotti, L Steffani, A Pagani, ...
European journal of pharmacology 641 (1), 29-34, 2010
Presence of 5α‐Reductase isozymes and aromatase in human prostate cancer cells and in benign prostate hyperplastic tissue
P Negri‐Cesi, A Poletti, A Colciago, P Magni, P Martini, M Motta
The Prostate 34 (4), 283-291, 1998
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
R Ross, IJ Neeland, S Yamashita, I Shai, J Seidell, P Magni, RD Santos, ...
Nature Reviews Endocrinology 16 (3), 177-189, 2020
Liver fat accumulation is associated with circulating PCSK9
M Ruscica, N Ferri, C Macchi, M Meroni, C Lanti, C Ricci, M Maggioni, ...
Annals of medicine 48 (5), 384-391, 2016
GC–MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect
F Gelmini, G Beretta, C Anselmi, M Centini, P Magni, M Ruscica, ...
International journal of pharmaceutics 440 (2), 170-178, 2013
Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus
M Ruscica, M Gomaraschi, G Mombelli, C Macchi, R Bosisio, ...
Journal of Clinical Lipidology 8 (1), 61-68, 2014
Suppressor of cytokine signaling-3 (SOCS-3) induces proprotein convertase subtilisin kexin type 9 (PCSK9) expression in hepatic HepG2 cell line
M Ruscica, C Ricci, C Macchi, P Magni, R Cristofani, J Liu, A Corsini, ...
Journal of Biological Chemistry 291 (7), 3508-3519, 2016
Hormonal control of the neuropeptide Y system
P Magni
Current Protein and Peptide Science 4 (1), 45-57, 2003
The system can't perform the operation now. Try again later.
Articles 1–20